Defective Slc7a7 transport reduces erythropoietin compromising erythropoiesis

The hematopoietic defects in the Lysinuric protein intolerance mouse model are not caused by intrinsic Slc7a7 loss in hematopoietic cells but rather by impaired erythropoietin production in the kidney. This finding opens potential avenues for therapeutic strategies targeting erythropoietin production to address hematological abnormalities in humans with lysinuric protein intolerance.

Authors

Institutions

Publication Details

Journal
Molecular Medicine
Published
2025-01-29
DOI
https://doi.org/10.1186/s10020-025-01100-0
Citations
3
Primary Topic
Erythrocyte Function and Pathophysiology
Type
article
Field-Weighted Citation Impact
3.49

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Defective Slc7a7 transport reduces erythropoietin compromising erythropoiesis

Günter Weiß, Gonzalo Hernández, David Sebastián, Judith Giroud‐Gerbetant et al.
3 citations
Molecular Medicine
Erythrocyte Function and Pathophysiology
3.49
article

Defective Slc7a7 transport reduces erythropoietin compromising erythropoiesis

Günter Weiß, Gonzalo Hernández, David Sebastián, Judith Giroud‐Gerbetant, Fernando Sotillo, Manuel Palacı́n, Neus Prats, Irene Ruano, Joana Fort, Mayka Sánchez, António Zorzano, Susanna Bodoy
article en
3 citations

Abstract

The hematopoietic defects in the Lysinuric protein intolerance mouse model are not caused by intrinsic Slc7a7 loss in hematopoietic cells but rather by impaired erythropoietin production in the kidney. This finding opens potential avenues for therapeutic strategies targeting erythropoietin production to address hematological abnormalities in humans with lysinuric protein intolerance.

Molecular MedicineVol. 31(1)
Universitat de Vic - Universitat Central de Catalunya (ES), Innsbruck Medical University (AT), Universität Innsbruck (AT), Instituto de Salud Carlos III (ES), Universitat Internacional de Catalunya (ES), Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (ES), Centre for Biomedical Network Research on Rare Diseases (ES), Centro de Investigación Biomédica en Red (ES), Institute for Research in Biomedicine (ES), Instituto de Investigación de Enfermedades Raras (ES), Institut de Biomedicina de la Universitat de Barcelona, Universitat de Barcelona (ES)
Generalitat de Catalunya, Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya, EMBO, Ministerio de Ciencia e Innovación, Ministerio de Ciencia y Tecnología
Openalex Percentile: Top 9%
Erythrocyte Function and Pathophysiology
3.49
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.